|
|||||
|
|
Lack of effect of dihydroergotamine on endothelial and smooth muscle cell proliferation and endothelial cell prostanoid production |
|
| Authors: | B. Lindblad W. E. Burkel T. W. Wakefield L. M. Graham J. C. Stanley |
| Affiliation: | (1) Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA;(2) Department of Anatomy and Cell Biology, University of Michigan Medical School, Ann Arbor, Michigan, USA;(3) Present address: Department of Surgery, University of Lund, Malmö General Hospital, S-21401 Malmö, Sweden |
| Abstract: | Summary The most important effect of dihydroergotamine is venoconstriction, but certain metabolic effects and changes in vessel prostanoid activity have also been suggested. In this study endothelial cell production of 6-keto PGF1  and TxB2 was quantitated in vitro. No evidence of altered prostanoid production was noted after incubation with dihydroergotamine (exposure ranging from 5×10–3 to 5×10–7 g/l). Similarly, no effect of dihydroergotamine on the growth rates of endothelial cells or smooth muscle cells in vitro was documented. |
| Keywords: | Dihydroergotamine endothelial cells smooth muscle cell prostanoid production |
| 本文献已被 SpringerLink 等数据库收录！ | |